Doximity Announces Impressive Financial Growth in Q4 and Fiscal Year 2025

Doximity, Inc. (NYSE: DOCS), the premier digital platform for U.S. medical professionals, recently released its financial results for the fourth quarter and the full fiscal year ended March 31, 2025. The numbers reveal striking growth, showcasing the company’s robust business model and its influential position within the healthcare sector.

Fiscal 2025 Fourth Quarter Highlights

Doximity achieved the following positive metrics during the fourth quarter:

Total Revenue: $138.3 million, marking a significant 17% increase year-over-year from $118.1 million.
Operating Cash Flow: A remarkable $98.5 million, a 54% growth from $63.9 million in the previous year.
Free Cash Flow: Totaling $97.0 million, up 56% compared to $62.3 million in Q4 of the prior year.

Key Financial Metrics

Performance Comparison

Here’s how the fiscal year 2025 numbers stacked up against the previous year:

Revenue: $570.4 million versus $475.4 million, an annual growth of 20%.
Net Income: Increased to $223.2 million from $147.6 million, showcasing a margin improvement from 31.0% to 39.1%.
Adjusted EBITDA: Rose to $313.8 million, a 36% yearly increase.

Subscription Revenue Growth

Doximity demonstrated impressive gains in subscription revenue, posting:

Q4 Subscription Revenue: $131.9 million, up 17% year-over-year.
Annual Subscription Revenue: $543.8 million, a 21% increase from the previous year.

Management’s Insight

Jeff Tangney, co-founder and CEO of Doximity, expressed his enthusiasm about the company’s performance, stating, “We closed out fiscal 2025 on a high note, with record engagement, strong profits, and 20% annual revenue growth. Our newsfeed, workflow, and AI tools all hit fresh highs in Q4, helping doctors save time and provide the best care for their patients.” This showcases Doximity’s ongoing commitment to enhancing the productivity of medical professionals.

Future Outlook

Looking ahead, Doximity has provided guidance for the first quarter ending June 30, 2025:

Projected Revenue: Between $139 million and $140 million.
Forecasted Adjusted EBITDA: Between $71 million and $72 million.

Annual Forecast

For the fiscal year ending March 31, 2026:

Expected Revenue: Between $619 million and $631 million.
Estimated Adjusted EBITDA: Between $333 million and $345 million.

Doximity’s results not only reflect its robust performance but also its strategic initiatives aimed at enriching healthcare workflows, further supporting medical professionals in their efforts to deliver exceptional patient care.

Tags:

Doximity, DOCS stock, financial results, revenue growth, healthcare technology, subscription revenue, medical professionals, fiscal year 2025, adjusted EBITDA, Jeff Tangney